Delaware’s Strategic Prevention Framework – Partnerships for Success (SPF-PFS) Community Evaluation Team (CET)
- Laura Rapp, Principal Investigator
- Steven S. Martin, Lead Evaluator
- Sharon Merriman-Nai, Evaluator
- Dana Holz, Evaluator
- Darryl Chambers, Evaluator
- David Borton, Data Analyst
- Robyn Blake, Graduate Research Assistant
- Shannon Streisel, Graduate Research Assistant
- Initiated: 2015; Funding Source: SAMHSA through Delaware’s
Division of Substance Abuse and Mental Health
SPF-PFS grant programs aim to reduce substance misuse and
strengthen prevention capacity at the state, tribe, and jurisdiction levels.
They do this by helping grantees leverage and realign statewide funding streams
for prevention. PFS is based on the premise that changes at the community level
will lead to measurable changes at the state level. Through collaboration, states
and their PFS-funded communities of high need can overcome challenges
associated with substance misuse.
SPF-PFS is a continuation of the work done under the
Strategic Prevention Framework – State Incentive Grant (SPF-SIG) (2009-2015)
and the goals of the SPF-PFS initiative are to provide funding to the State in
order to: (1) Prevent onset and reduce the progression of substance abuse,
including childhood and underage drinking and prescription drug abuse; (2)
Reduce substance abuse-related problems; and (3) Build prevention capacity and
infrastructure at the state and community level.
The Partnerships for Success Community Evaluation Team (PFS
CET) provides process and outcome evaluation services for all SPF-PFS funded
community prevention Contractors as well as the PFS Management Team at DSAMH.
The evaluation services include technical assistance and guidance on the five
steps of the SPF Framework: Assessment, Capacity Building, Planning,
Implementation, and Evaluation.
Consequently, the Community Evaluation Team provides guidance, technical
assistance, data collection and data analysis that are specific to where each
Community/State Contractor is in regards to the SPF process. Additionally, the
CET works collaboratively with PFS Management, Community Contractors, and the
Federal Cross-Site Evaluation Team to ensure that all process and outcome
requirements are met for this project.
PFS Annual Report 2017.pdf
PFS Annual Report 2018.pdf
Delaware’s Strategic Prevention Framework for Prescription Drugs (SPF Rx)
- Laura Rapp, Principal Investigator
- Dana Holz, Evaluator
- Robyn Blake, Graduate Research Assistant
- Shannon Streisel, Graduate Research Assistant
- UD was contracted during Year 1 and Year 3 of this 5-year project for evaluation
Delaware's Strategic Prevention Framework for Prescription Drugs (SPF Rx) is intended to raise awareness about the risks of sharing medications, and promote collaboration between states/tribes and pharmaceutical and medical communities to understand the risks of overprescribing to Delaware residents ages 12-25 and across the lifespan. SPF Rx is built on a community based approach to prevention and a series of implementation principles that can be operationalized at the Federal, State, and community levels. Funding is provided by the Substance Abuse and Mental Health Services Administration, Center for the Substance Abuse Prevention (SAMHSA/CSAP). The Delaware SPF Rx is administered by Delaware's Department of Health and Social Services, Division of Substance Abuse and Mental Health (DHSS/DSAMH). The Evaluation Team works with funded community agencies and the State to evaluate ongoing prevention efforts funded through SPF Rx. The Evaluation Team tracks and reports on process and outcome measures using data from prevention activity track tools, the Prescription Drug Monitoring Program (PDMP) data, emergency department data, and Delaware School Survey data. Additionally, the Evaluation Team provides tailored technical assistance to the funded community agencies as they plan and implement their prescription drug abuse prevention efforts.
SPF Rx Evaluation Report 2019.pdf